Page 5 - Y Mabs Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

43,700 Shares in Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) Bought by Sapient Capital LLC

43,700 Shares in Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) Bought by Sapient Capital LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesExchange traded conceptsSecurities exchange commissionSg americas securitiesY mabs therapeutics incSapient capitalCanaccord genuity groupMirae asset global investments coChina universal asset management coBailard incY mabs therapeuticsFree reportUniversal asset managementAsset global investmentsTraded conceptsAbs therapeutics

Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments

Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Mccormick placeUnited statesBo kruseMarya tagliaferriCourtney duganMike rossiAmerican society of clinical oncologyBrazilian medicines market regulation chamberCompany quarterly report on formGlobe newswirey mabs therapeutics incAssembly disassemblyY mabs therapeutics incSecurities exchangeMemorial sloan kettering cancer centerCompany annual report on formAbs reports first quarter

Y-mAbs Therapeutics (YMAB) Set to Announce Quarterly Earnings on Tuesday

Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.12) per share for the quarter. Y-mAbs Therapeutics has set its FY 2024 guidance at EPS.Investors that are interested in participating in the company’s […]

United statesCanaccord genuity groupY mabs therapeutics incY mabs therapeuticsGet free reportAbs therapeuticsY mabs therapeutics daily

Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024

Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Bo kruseSue smithCourtney duganMichael rossiAssembly disassemblyCompany annual report on formGlobe newswirey mabs therapeutics incY mabs therapeutics incSecurities exchangeAnnounce first quarterOperating resultsAbs therapeuticsChief executive officerChief commercial officerVignesh rajahChief medical officer

Critical Comparison: Dyne Therapeutics (NASDAQ:DYN) versus Y-mAbs Therapeutics (NASDAQ:YMAB)

Dyne Therapeutics (NASDAQ:DYN – Get Free Report) and Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership. Valuation & Earnings This table compares Dyne Therapeutics […]

United statesNew yorkMassachusetts institute of technologyMemorial sloan kettering cancer centerDyne therapeutics incY mabs therapeutics incDyne therapeuticsGet free reportY mabs therapeuticsY mabs therapeuticAbs therapeuticsGiven dyne therapeuticMassachusetts instituteDyne therapeutics daily